Results 1 to 10 of about 3,002,254 (310)
Primary stroke prevention worldwide: translating evidence into action [PDF]
Lancet Public Health, 2021 Summary Stroke is the second leading cause of death and the third leading cause of disability worldwide and its burden is increasing rapidly in low-income and middle-income countries, many of which are unable to face the challenges it imposes.
M. Owolabi +176 more
semanticscholar +2 more sources
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
New England Journal of Medicine, 2018 Background Embolic strokes of undetermined source represent 20% of ischemic strokes and are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an oral factor Xa inhibitor, may result in a lower risk of recurrent stroke ...
Hardi Mundl, , Raf Brouns
exaly +2 more sources
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
New England Journal of Medicine, 2019 Background Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most cryptogenic strokes are considered to be embolic and of undetermined source.
Jeffrey Saver, , Byung-Chul Lee
exaly +2 more sources
Postgraduate Medical Journal, 1995 Stroke is ideally suited for prevention. It has a high prevalence, burden of illness, and economic cost, and safe and effective prevention measures. The estimated $30 billion that is being spent for stroke each year in the United States should not come as a surprise given the approximately 3 million stroke survivors and 400,000 to 500,000 new or ...
R, Tozer, I R, Hastie
openaire +4 more sources
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
New England Journal of Medicine, 2023 BACKGROUND Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators.
J. Healey +36 more
semanticscholar +1 more source
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Europace, 2023 Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of this common arrhythmia. Substantial advances in the epidemiology and associated pathophysiology underlying AF-related stroke and thrombo-embolism are evident ...
G. Lip +10 more
semanticscholar +1 more source
Thrombosis and Haemostasis, 2021 The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners ...
T. Chao +10 more
semanticscholar +1 more source
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Circulation, 2023 Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking,
C. Tsao +42 more
semanticscholar +1 more source
Stroke, 2021 Supplemental Digital Content is available in the text. Background: Dual antiplatelet therapy (DAPT) after ischemic stroke or transient ischemic attack may reduce recurrent stroke but also increase severe bleeding compared with single antiplatelet therapy
Devin L. Brown +8 more
semanticscholar +1 more source